Efficacy and Safety of Cisplatin Versus Carboplatin for Patients With Squamous Cell Carcinoma of Head and Neck: A Systematic Review and Meta‐Analysis
Head & Neck · 2026-12 · 48 (12) · 3501-3513
DOI: 10.1002/hed.70485 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Head & Neck, online erschienen am 05.10.2026. Verfasst von Samiya Rahim und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Ayub Medical College, Abbottabad, Pakistan. Hauptthemen laut MEDLINE: Carboplatin, Cisplatin, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Cisplatin‐ and carboplatin‐based regimens are widely used in the treatment of head and neck squamous cell carcinoma (HNSCC), yet comparative evidence on survival and toxicity outcomes remains limited. While cisplatin is standard in many settings, carboplatin is often preferred in patients with comorbidities or impaired renal function. This systematic review and meta‐analysis aimed to synthesize available evidence comparing cisplatin versus carboplatin in HNSCC.
Methods
A comprehensive literature search was conducted in PubMed, Embase, and the Cochrane Library from inception to February 2026. Randomized and observational studies comparing cisplatin‐ and carboplatin‐based regimens in HNSCC were included. Primary outcomes were overall survival (OS), progression‐free survival (PFS), locoregional recurrence‐free survival at 1, 3, and 5 years and distant metastasis‐free survival (DMFS) at 1 and 3 years. Secondary outcomes include grade ≥ 3 toxicities. Data were pooled using random‐effects meta‐analysis.
Results
Eight studies comprising 1044 patients were included, including four recently published studies not previously pooled in head‐to‐head analyses. Pooled analyses showed no statistically significant differences between cisplatin and carboplatin in OS, PFS, LRRFS, or DMFS overall. Subgroup analyses across 1, 3, and 5‐year follow‐up intervals likewise demonstrated no significant differences for most outcomes. The only significant finding was a modest difference in 5‐year LRRFS favoring cisplatin, based on only two studies. No statistically significant differences were observed in grade ≥ 3 anemia, leukopenia, thrombocytopenia, or nausea/vomiting.
Conclusions
Cisplatin and carboplatin‐based regimens yield largely comparable survival and toxicity outcomes in HNSCC. Treatment selection should be guided by patient comorbidities and tolerability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Ayub Medical College, Abbottabad, Pakistan.
- Department of Medicine, Liaquat University of Medical and Health Sciences, Karachi, Pakistan.
- Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
- Department of Medicine, Bacha Khan Medical College, Mardan, Pakistan.
- Department of Medicine, Khyber Medical College, Peshawar, Pakistan.
- Department of Medicine, Fatima Jinnah Medical University, Lahore, Pakistan.
ORCID-Profile: Samiya Rahim, Muskan Kumari, Eisha Abid, Fatima Sajjad, Muskan Hotak, Malaika Saqib, Fazia Khattak, Umar Anwar, Hassan Hanif, Syed Ikram Ullah
Zitieren
APA
Rahim, S., Kumari, M., Abid, E., Hoti, R. K., Sajjad, F., Khan, F. T. Z. H., Hotak, M., Afridi, S., Ali, A., Muhammad, H., Saqib, M., Khattak, F., Anwar, U., Nasar, M., Din, N. U., Ahmed, A., Hanif, H., Ullah, S. I., & Afridi, A. (2026). Efficacy and Safety of Cisplatin Versus Carboplatin for Patients With Squamous Cell Carcinoma of Head and Neck: A Systematic Review and Meta‐Analysis. Head & Neck, 48(12), 3501-3513. https://doi.org/10.1002/hed.70485
Vancouver
Rahim S, Kumari M, Abid E, Hoti RK, Sajjad F, Khan FTZH, et al. Efficacy and Safety of Cisplatin Versus Carboplatin for Patients With Squamous Cell Carcinoma of Head and Neck: A Systematic Review and Meta‐Analysis. Head & Neck. 2026;48(12):3501-3513. doi:10.1002/hed.70485
BibTeX
@article{Rahim2026,
author = {Rahim, Samiya and Kumari, Muskan and Abid, Eisha and Hoti, Rida Khan and Sajjad, Fatima and Khan, Fatima Tu Zahra Hafeez and Hotak, Muskan and Afridi, Salma and Ali, Ahmad and Muhammad, Hassaan and Saqib, Malaika and Khattak, Fazia and Anwar, Umar and Nasar, Marwa and Din, Nisar Ud and Ahmed, Aamir and Hanif, Hassan and Ullah, Syed Ikram and Afridi, Abdullah},
title = {Efficacy and Safety of Cisplatin Versus Carboplatin for Patients With Squamous Cell Carcinoma of Head and Neck: A Systematic Review and Meta‐Analysis},
journal = {Head & Neck},
year = {2026},
volume = {48},
number = {12},
pages = {3501--3513},
doi = {10.1002/hed.70485}
}
EUVIMED